➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Colorcon
AstraZeneca
Medtronic
Baxter

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

BOTOX COSMETIC Drug Profile


Email this page to a colleague

« Back to Dashboard

Summary for Tradename: BOTOX COSMETIC
Recent Clinical Trials for BOTOX COSMETIC

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Hospices Civils de LyonN/A
Carilion ClinicEarly Phase 1
Assiut UniversityPhase 4

See all BOTOX COSMETIC clinical trials

Pharmacology for BOTOX COSMETIC

Company Disclosures: US Patents for BOTOX COSMETIC

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Get Started Free The Regents of the University of Colorado (Boulder, CO) 2017-07-15 RX company
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Get Started Free Allergan, Inc. (Irvine, CA) 2013-12-28 RX company
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Get Started Free Allergan, Inc. (Irvine, CA) 2013-12-28 RX company
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Get Started Free Allergan, Inc. (Irvine, CA) 2013-12-28 RX company
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Get Started Free The Regents of the University of Colorado (Boulder, CO) 2017-07-15 RX company
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Get Started Free The Regents of the University of Colorado (Boulder, CO) 2017-07-15 RX company
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Get Started Free The Regents of the University of Colorado (Denver, CO) 2017-07-15 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for BOTOX COSMETIC

These patents were identified by searching patent claims

Supplementary Protection Certificates for BOTOX COSMETIC

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
122012000064 Germany   Get Started Free
509 Finland   Get Started Free
132008901655480 Italy   Get Started Free PRODUCT NAME: NEUROTOSSINA DI CLOSTRIDIUM BOTULINUM DI TIPO A (150 KD) PRIVA DI PROTEINE COMPLESSATE(XEOMIN); AUTHORISATION NUMBER(S) AND DATE(S): 838, 20080409;57093.00.00, 20050531
CR 2013 00041 Denmark   Get Started Free PRODUCT NAME: BOTULINUM TOXIN, HERUNDER BOTULINUM TOXIN A; NAT. REG. NO/DATE: 43623, 31350, 46039 (DK) 20130219; FIRST REG. NO/DATE: FI 25162,15424, 28146 20130116
C300654 Netherlands   Get Started Free PRODUCT NAME: BOTULINUM TOXINE, TYPE A; NAT. REGISTRATION NO/DATE: RVG 17379RVG 32957RVG 32958 20131029; FIRST REGISTRATION:
92250 Luxembourg   Get Started Free PRODUCT NAME: TOXINE BOTULIQUE DE TYPE A DE CLOSTRIDIUM BOTULINUM
300563 Netherlands   Get Started Free DETAILS ASSIGNMENT: VERANDERING VAN EIGENAAR(S), OVERDRACHT
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
AstraZeneca
Dow
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.